Patents by Inventor Andrew Griffiths

Andrew Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10360044
    Abstract: Systems for management of a large computing cluster. A set of computing nodes within the cluster are identified. The identified nodes are to be reimaged with an operating system image and parameters. One or more reimaging algorithms in the form of computer code are stored in a networked storage device within a storage pool that comprises the networked storage device and a plurality of local storage devices that correspond to respective individual ones of the set of computing nodes. An agent that can execute the reimaging algorithm code is configured to run on any one of the set of computing nodes, wherein the agent is further configured to retrieve reimaging data from a storage device that is within the storage pool. An agent running on a leader node initiates reimaging of a second node. The second node initiates reimaging of a third node. The third node reimages the leader node.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: July 23, 2019
    Assignee: Nutanix, Inc.
    Inventors: Jan Ralf Alexander Olderdissen, Miao Cui, Brian Andrew Griffiths Finn, Mengyang Li
  • Patent number: 10358747
    Abstract: A pulley for installation in a pulley mechanism of a Jacquard machine has a shaft, a housing having two flank bodies, which are provided to fasten the shaft, so that this shaft extends substantially between the flank bodies, and a pulley wheel, which is provided to be arranged between the two flank bodies so as to be directly rotatable around the shaft. The shaft, prior to assembly of the pulley, is provided with cavities and/or projecting portions for the post-assembly axial securement of the flank bodies in both axial directions.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: July 23, 2019
    Assignee: NV MICHEL VAN DE WIELE
    Inventors: Frederik De Medts, John Andrew Griffiths, Matthew Theobald
  • Publication number: 20190218218
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use to thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 18, 2019
    Applicant: Pfizer Inc.
    Inventors: Mary Theresa Didiuk, Robert Lee Dow, David Andrew Griffith
  • Publication number: 20190155613
    Abstract: Systems for management of a large computing cluster. A set of computing nodes within the cluster are identified. The identified nodes are to be reimaged with an operating system image and parameters. One or more reimaging algorithms in the form of computer code are stored in a networked storage device within a storage pool that comprises the networked storage device and a plurality of local storage devices that correspond to respective individual ones of the set of computing nodes. An agent that can execute the reimaging algorithm code is configured to run on any one of the set of computing nodes, wherein the agent is further configured to retrieve reimaging data from a storage device that is within the storage pool. An agent running on a leader node initiates reimaging of a second node. The second node initiates reimaging of a third node. The third node reimages the leader node.
    Type: Application
    Filed: September 13, 2016
    Publication date: May 23, 2019
    Applicant: Nutanix, Inc.
    Inventors: Jan Ralf Alexander OLDERDISSEN, Miao CUI, Brian Andrew Griffiths FINN, Mengyang LI
  • Patent number: 10294225
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: May 21, 2019
    Assignee: Pfizer Inc.
    Inventors: Mary Didiuk, Robert Lee Dow, David Andrew Griffith
  • Publication number: 20180162858
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: January 30, 2018
    Publication date: June 14, 2018
    Applicant: PFIZER INC.
    Inventors: Mary Didiuk, Robert Lee Dow, David Andrew Griffith
  • Patent number: 9925504
    Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalizing two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reactions between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control; preferably electronic microfluidic control The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co-compartmentalized into the microcapsules.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: March 27, 2018
    Assignees: President and Fellows of Harvard College, Medical Research Council
    Inventors: Andrew Griffiths, David Weitz, Keunho Ahn, Darren Link, Jerome Bibette
  • Patent number: 9908883
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: March 6, 2018
    Assignee: Pfizer Inc.
    Inventors: Mary Didiuk, Robert Lee Dow, David Andrew Griffith
  • Publication number: 20180044821
    Abstract: A pulley (1) for installation in a pulley mechanism of a Jacquard machine, comprising a shaft (3); a housing (4), comprising two flank bodies (5), which are provided to fasten the shaft (3), so that this shaft (3) extends substantially between the flank bodies (5); and a pulley wheel (6), which is provided to be arranged between the two flank bodies (5) so as to be directly rotatable around the shaft (3); wherein the shaft (3), prior to assembly of the pulley (1), is provided with cavities (7, 10, 11) and/or projecting portions for the post-assembly axial securement of the flank bodies (5) in both axial directions.
    Type: Application
    Filed: January 20, 2016
    Publication date: February 15, 2018
    Inventors: Frederik DE MEDTS, John Andrew GRIFFITHS, Matthew THEOBALD
  • Patent number: 9839890
    Abstract: The invention describes a method for the synthesis of compounds comprising the steps of: (a) compartmentalising two or more sets of primary compounds into microcapsules; such that a proportion of the microcapsules contains two or more compounds; and (b) forming secondary compounds in the microcapsules by chemical reactions between primary compounds from different sets; wherein one or both of steps (a) and (b) is performed under microfluidic control; preferably electronic microfluidic control, The invention further allows for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, and which is co-compartmentalised into the microcapsules.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: December 12, 2017
    Assignees: National Science Foundation, Medical Research Council, President and Fellows of Harvard College
    Inventors: Andrew Griffiths, David Weitz, Darren Link, Keunho Ahn, Jerome Bibette
  • Patent number: 9725831
    Abstract: A module suitable for installation in a jacquard machine, comprising at least one partition provided for guiding shed-forming elements, wherein the shed-forming elements comprise at least one anchor element which is configured to be held pressed against a contact profile of the jacquard machine when the module has been installed in the jacquard machine, wherein said anchor element is displaceable from a first position of use to a second removal position for removing the module from the jacquard machine.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: August 8, 2017
    Assignee: NV MICHEL VAN DE WIELE
    Inventors: Bram Vanderjeugt, Günther Devloo, John Andrew Griffiths
  • Patent number: 9528106
    Abstract: The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising of the steps of: (a) compartmentalizing genetic elements into microcapsules; (b) expressing the genetic elements to produce their respective gene products within the microcapsules; (c) sorting the genetic elements which produce the gene product having a desired activity. The invention enables the in vitro evolution of nucleic acids by repeated mutagenesis and iterative applications of the method of the invention.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: December 27, 2016
    Assignee: Medical Research Council
    Inventors: Andrew Griffiths, Dan Tawfik
  • Publication number: 20160347752
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: August 15, 2016
    Publication date: December 1, 2016
    Applicant: PFIZER INC.
    Inventors: Mary Didiuk, Robert Lee Dow, David Andrew Griffith
  • Patent number: 9498759
    Abstract: The invention describes a method for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, comprising the steps of: a) compartmentalizing the compounds into microcapsules together with the target, such that only a subset of the repertoire is represented in multiple copies in any one microcapsule; and b) identifying the compound which binds to or modulates the activity of the target; wherein at least one step is performed under microfluidic control. The invention enables the screening of large repertoires of molecules which can serve as leads for drug development.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: November 22, 2016
    Assignees: President and Fellows of Harvard College, Medical Research Council
    Inventors: Andrew Griffiths, David Weitz, Keunho Ahn, Darren R. Link, Jerome Bibette
  • Publication number: 20150376185
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: September 11, 2015
    Publication date: December 31, 2015
    Applicant: PFIZER INC.
    Inventors: Mary Theresa Didiuk, Robert Lee Dow, David Andrew Griffith
  • Publication number: 20150336958
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 areas described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: August 7, 2015
    Publication date: November 26, 2015
    Applicant: PFIZER INC.
    Inventors: Robert Lee Dow, David James Edmonds, David Andrew Griffith, James Alfred Southers, JR.
  • Publication number: 20150299912
    Abstract: A module suitable for installation in a jacquard machine, comprising at least one partition provided for guiding shed-forming elements, wherein the shed-forming elements comprise at least one anchor element which is configured to be held pressed against a contact profile of the jacquard machine when the module has been installed in the jacquard machine, wherein said anchor element is displaceable from a first position of use to a second removal position for removing the module from the jacquard machine.
    Type: Application
    Filed: November 18, 2013
    Publication date: October 22, 2015
    Applicant: NV Michel Van De Wiele
    Inventors: Bram Vanderjeugt, Günther Devloo, John Andrew Griffiths
  • Patent number: 9145416
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: September 29, 2015
    Assignee: Pfizer Inc.
    Inventors: Mary Theresa Didiuk, Robert Lee Dow, David Andrew Griffith
  • Patent number: 9139587
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: September 22, 2015
    Assignee: Pfizer Inc.
    Inventors: Scott William Bagley, David Andrew Griffith, Daniel Wei-Shung Kung
  • Publication number: 20150112068
    Abstract: The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 areas described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
    Type: Application
    Filed: January 9, 2015
    Publication date: April 23, 2015
    Applicant: PFIZER INC.
    Inventors: Robert Lee Dow, David James Edmonds, David Andrew Griffith, James Alfred Southers, JR.